The association between continuous positive airway pressure therapy and liver disease development in obstructive sleep apnea/hypopnea syndrome patients: a nationwide population-based cohort study in Taiwan.

Liang-Wen HangChi-Fung ChenChang-Bi WangTrong-Neng WuWen-Miin LiangTzu-Chieh Chou

Published in: Sleep & breathing = Schlaf & Atmung (2016)

Our observations suggest that CPAP treatment may play an important role to delay the progression of liver disease in OSAHS patients and decreases the incidence of liver disease among OSAHS patients. Thus, CPAP therapy may be a feasible way to decrease the risk of liver disease among patients with OSAHS.

Keyphrases

obstructive sleep apnea
positive airway pressure
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
sleep apnea
prognostic factors
peritoneal dialysis
stem cells
patient reported outcomes
risk factors
smoking cessation